Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy-Reference-Cited by-同舟云学术

Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy

Published:2022-03-21 Issue:7 Volume:65 Page:5149-5183
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Tan Lun¹²³,Zhang Jifa¹²³,Wang Yuxi¹²³^ORCID,Wang Xiye¹,Wang Yanyan¹,Zhang Zhixiong¹,Shuai Wen¹²³,Wang Guan¹,Chen Juncheng¹²³,Wang Chengdi¹²,Ouyang Liang¹²³^ORCID,Li Weimin¹²³^ORCID

Affiliation:

1. Department of Respiratory and Critical Care Medicine, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041 Sichuan, China

2. Targeted Tracer Research and Development Laboratory, Institute of Respiratory Health, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041 Sichuan, China

3. Precision Medicine Key Laboratory of Sichuan Province and Precision Medicine Research Center, West China Hospital, Sichuan University, Chengdu, 610041 Sichuan, China

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

National Clinical Research Center for Geriatrics, Sichuan University

Sichuan Science and Technology Program

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c01714

Reference174 articles.